<code id='7E5E49EBBD'></code><style id='7E5E49EBBD'></style>
    • <acronym id='7E5E49EBBD'></acronym>
      <center id='7E5E49EBBD'><center id='7E5E49EBBD'><tfoot id='7E5E49EBBD'></tfoot></center><abbr id='7E5E49EBBD'><dir id='7E5E49EBBD'><tfoot id='7E5E49EBBD'></tfoot><noframes id='7E5E49EBBD'>

    • <optgroup id='7E5E49EBBD'><strike id='7E5E49EBBD'><sup id='7E5E49EBBD'></sup></strike><code id='7E5E49EBBD'></code></optgroup>
        1. <b id='7E5E49EBBD'><label id='7E5E49EBBD'><select id='7E5E49EBBD'><dt id='7E5E49EBBD'><span id='7E5E49EBBD'></span></dt></select></label></b><u id='7E5E49EBBD'></u>
          <i id='7E5E49EBBD'><strike id='7E5E49EBBD'><tt id='7E5E49EBBD'><pre id='7E5E49EBBD'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:519
          The cost of healthcare health technology assessment
          APStock

          Physicians are in line to absorb more Medicare cuts next year, while hospital outpatient departments and surgery centers will get billions in new revenue.

          The base figure that determines how much physicians get paid by Medicare will decrease by 3.3% for 2024, the federal government said Thursday.

          advertisement

          The cuts will not be distributed equally among all specialties. Indeed, primary care doctors, endocrinologists, nurse practitioners, and physician assistants would see their Medicare payment rates rise, on average, according to the annual payment rule. Cuts would be steepest for all types of radiologists, including interventionalists and nuclear medicine, as well as vascular surgeons.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers
          Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

          AdobeWhenitcomestobringinganexperimentaldrugtomarketandsellingit,NovoNordisk,themakeroftheweightloss

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Leqembi, other new Alzheimer’s drugs require better biomarkers

          AdobeTherecentFDAapprovalofLeqembi,thelatestanti-amyloiddrug,isundoubtedlyabreakthroughforthefield,p